DATA TECHNICAL (GLASGOW) LIMITED

Company number SC368317 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: DATA TECHNICAL (GLASGOW) LIMITED

1. Financial Health Score: D-

This company is displaying critical symptoms of financial distress. With net liabilities exceeding assets by over £54,000 and a rapidly deteriorating balance sheet, the patient is in serious condition. The business has been technically insolvent for three consecutive years, with the "health deficit" widening each year. While the company remains operational, its financial vital signs suggest it is surviving on life support — likely through director loans or creditor forbearance — rather than from underlying financial strength.


2. Key Vital Signs

Vital Sign 2024 Value 2023 Value Trend Interpretation
Net Assets (£54,144) (£41,971) ⬇ Worsening Deepening insolvency — the "patient" is bleeding reserves
Total Assets £127,322 £70,251 ⬆ Increasing Asset growth, but driven by fixed asset purchase
Total Liabilities £181,466 £112,222 ⬆ Increasing Debts growing at alarming rate (+62%)
Current Assets £76,212 £68,048 ⬆ Slight increase Modest improvement in short-term resources
Creditors (< 1 year) £181,466 £112,222 ⬆ Increasing All liabilities are short-term — immediate pressure
Net Current Liabilities (£105,254) (£44,174) ⬇ Worsening Working capital has collapsed — severe liquidity crisis
Fixed Assets £51,110 £2,203 ⬆ Massive jump Significant capital investment in 2024
Current Ratio 0.42:1 0.61:1 ⬇ Declining Less than 50p to cover every £1 of short-term debt
Share Capital £1 £1 ➡ Flat Minimal equity base — no capital buffer

10-Year Historical Trajectory

Year Net Assets Health Indicator
2015 £42,137 ✅ Healthy
2016 £51,262 ✅ Peak health
2017 £45,758 ✅ Healthy
2018 £31,367 ⚠️ Declining
2019 £36,025 ⚠️ Recovering
2020 £33,268 ⚠️ Stable but lower
2021 £37,856 ⚠️ Brief recovery
2022 (£40,027) 🔴 Insolvency onset
2023 (£41,971) 🔴 Chronic condition
2024 (£54,144) 🔴 Critical deterioration

3. Diagnosis

Primary Condition: Chronic Insolvency with Acute Liquidity Failure

The financial data reveals a business that has been in a state of technical insolvency since 2022, with the condition progressively worsening. Like a patient with a chronic illness that has been left untreated, the deficit has grown from £40,027 to £54,144 — a 35% increase in the "health gap" over three years.

Symptom Analysis:

1. The Liability Tumour (£181,466 in short-term debts) The most alarming symptom is the dramatic growth in creditors due within one year, which surged by £69,244 (62%) in a single year. This suggests the business is funding operations through unpaid supplier debts, deferred payments, or director loans rather than through revenue generation. All liabilities are current — there is no long-term debt structure, meaning every penny owed is pressing on the company immediately.

2. The Working Capital Collapse (Net Current Liabilities: £105,254) The current ratio of 0.42:1 is critically unhealthy. A healthy business typically maintains a ratio of 1.5:1 or above. At 0.42:1, the company has only 42p available to pay every £1 owed within the next 12 months. This is the financial equivalent of hypoxia — the business is starved of the working capital oxygen it needs to function.

3. The Fixed Asset Anomaly (£51,110 vs £2,203) The dramatic increase in fixed assets suggests a significant capital purchase in 2024 — potentially equipment, vehicles, or technology infrastructure given the IT services nature of the business. However, this investment appears to have been funded entirely by debt rather than retained earnings or equity, which has exacerbated the liability position. Investing while insolvent is like undertaking major surgery while the patient is in cardiac arrest.

4. The Vanishing Equity Buffer From 2015-2021, the company maintained positive net assets between £31,000-£51,000. This equity buffer — the business's immune system — has been completely eroded and replaced with a growing deficit. With share capital of only £1, there is virtually no owner investment standing behind the business.

5. Director Considerations: Trading Whilst Insolvent The directors (Douglas Andrew Lyle and Paul Ritchie) should be acutely aware of their legal position. Under UK insolvency law, specifically the Insolvency Act 1986, directors who continue trading when they know (or should know) there is no reasonable prospect of avoiding insolvency may face personal liability for wrongful trading. This is the financial equivalent of a "do not resuscitate" threshold being crossed — continuing without a credible recovery plan exposes directors to serious personal consequences.

6. Micro-Entity Filing: Limited Transparency The company files as a micro-entity, which means it takes advantage of minimal disclosure requirements. No profit and loss account is filed, no detailed breakdown of creditors is provided, and there is no auditor scrutiny. While legally permissible, this reduced transparency makes it impossible to assess revenue, profitability, or the composition of the growing creditor balance from public filings alone.


4. Prognosis

Outlook: Guarded to Poor — Without intervention, likely terminal within 12-24 months

The trajectory is unmistakably negative. Three consecutive years of deepening insolvency, accelerating liabilities, and collapsing working capital suggest the business model is not generating sufficient returns to service its obligations. The recent fixed asset investment may represent a turnaround attempt, but it has paradoxically worsened the financial position by increasing debt without (yet) generating corresponding returns.

Potential Scenarios:

Scenario Probability Timeline
Continued decline — Liabilities continue to grow, eventual creditor action High 12-24 months
Director-led recovery — Restructuring, new investment, or profitable contracts Medium 6-18 months
Formal insolvency — Administration, creditors' voluntary liquidation Medium-High 6-12 months
Creditor-led winding up — Petition from unpaid suppliers Medium 3-12 months

5. Recommendations

Immediate (0-3 months):

  1. Emergency Cash Flow Assessment: Conduct a rigorous 13-week cash flow forecast to understand whether the business can meet its immediate obligations. This is the financial equivalent of stabilising the patient's airway — without cash, nothing else matters.

  2. Director Loan Review: Determine what proportion of the £181,466 in creditors represents director loans. If directors have lent money to the business, this provides some flexibility (directors may subordinate their claims). If the debts are predominantly to trade creditors or HMRC, the position is far more precarious.

  3. Creditor Ageing Analysis: Identify which creditors are overdue and by how long. HMRC debts (VAT, PAYE, Corporation Tax) carry the most immediate threat of enforcement action.

  4. Seek Professional Insolvency Advice: The directors should urgently consult a licensed insolvency practitioner to understand their options and personal exposure. This is not an admission of defeat — it is responsible governance.

Short-term (3-6 months):

  1. Creditor Negotiation: If the business is viable but overleveraged, negotiate time-to-pay arrangements with key creditors. HMRC's Time to Pay arrangement may be available for tax debts.

  2. Cost Restructuring: Review all operational costs ruthlessly. With only 4 employees, the cost base may already be lean, but every expense should be challenged.

  3. Revenue Acceleration: Focus on converting outstanding receivables (included in current assets) into cash. Consider offering early payment discounts to clients.

Medium-term (6-12 months):

  1. Capital Injection or Restructuring: If the business has a viable core, the directors should consider formal capital restructuring — potentially through a Company Voluntary Arrangement (CVA) to compromise debts with creditors while continuing to trade.

  2. Asset Utilisation Review: The significant fixed asset investment should be generating returns. Assess whether this investment is being effectively deployed, or whether assets should be disposed of to reduce liabilities.

  3. Consider Whether the Business is Viable: The most difficult but important question — is there a profitable business underneath the debt? If revenue cannot cover costs and service debts, the most responsible action may be an orderly wind-down through a creditors' voluntary liquidation.


Risk Warnings

⚠️ Director Personal Liability Risk: Trading whilst insolvent creates significant personal liability exposure for directors under Section 214 of the Insolvency Act 1986.

⚠️ HMRC Enforcement: If tax debts are included in the creditor balance, HMRC can issue winding-up petitions with minimal notice.

⚠️ Limited Public Information: Micro-entity accounts provide minimal transparency. The true financial position may be better or worse than visible from public filings.


Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 31 August 2026